Pulmatrix Dividend Paid And Capex Coverage Ratio from 2010 to 2024
| PULM Stock | USD 1.92 0.09 4.92% |
Dividend Paid And Capex Coverage Ratio | First Reported 2010-12-31 | Previous Quarter 23.6464497 | Current Value 22.46 | Quarterly Volatility 220.67582724 |
Check Pulmatrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmatrix main balance sheet or income statement drivers, such as Interest Expense of 185.2 K, Other Operating Expenses of 16.9 M or Research Development of 10.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.88, Dividend Yield of 0.0 or PTB Ratio of 0.4. Pulmatrix financial statements analysis is a perfect complement when working with Pulmatrix Valuation or Volatility modules.
Pulmatrix | Dividend Paid And Capex Coverage Ratio |
Latest Pulmatrix's Dividend Paid And Capex Coverage Ratio Growth Pattern
Below is the plot of the Dividend Paid And Capex Coverage Ratio of Pulmatrix over the last few years. It is Pulmatrix's Dividend Paid And Capex Coverage Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulmatrix's overall financial position and show how it may be relating to other accounts over time.
| Dividend Paid And Capex Coverage Ratio | 10 Years Trend |
|
Dividend Paid And Capex Coverage Ratio |
| Timeline |
Pulmatrix Dividend Paid And Capex Coverage Ratio Regression Statistics
| Arithmetic Mean | 129.07 | |
| Coefficient Of Variation | 170.97 | |
| Mean Deviation | 123.14 | |
| Median | 46.89 | |
| Standard Deviation | 220.68 | |
| Sample Variance | 48,698 | |
| Range | 938 | |
| R-Value | 0.04 | |
| Mean Square Error | 52,338 | |
| R-Squared | 0 | |
| Significance | 0.87 | |
| Slope | 2.21 | |
| Total Sum of Squares | 681,769 |
Pulmatrix Dividend Paid And Capex Coverage Ratio History
About Pulmatrix Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Pulmatrix income statement, its balance sheet, and the statement of cash flows. Pulmatrix investors use historical funamental indicators, such as Pulmatrix's Dividend Paid And Capex Coverage Ratio, to determine how well the company is positioned to perform in the future. Although Pulmatrix investors may use each financial statement separately, they are all related. The changes in Pulmatrix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pulmatrix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pulmatrix Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pulmatrix. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 23.65 | 22.46 |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pulmatrix using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Pulmatrix Correlation against competitors. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Pulmatrix Stock analysis
When running Pulmatrix's price analysis, check to measure Pulmatrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmatrix is operating at the current time. Most of Pulmatrix's value examination focuses on studying past and present price action to predict the probability of Pulmatrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmatrix's price. Additionally, you may evaluate how the addition of Pulmatrix to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Pulmatrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.87) | Revenue Per Share 1.998 | Quarterly Revenue Growth 0.289 | Return On Assets (0.25) | Return On Equity (0.58) |
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.